Data as of Nov 21
| +0.28 / +0.47%|
The 19 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 64.00, with a high estimate of 72.00 and a low estimate of 57.00. The median estimate represents a +7.27% increase from the last price of 59.66.
The current consensus among 21 polled investment analysts is to Hold stock in Merck & Co Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.